Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Clin Neuropharmacol ; 23(2): 86-9, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-10803798

RESUMEN

We present two patients with epilepsy who experienced disabling myoclonic jerks during lamotrigine treatment. Both were young males who had intractable cryptogenic generalized epilepsy since childhood. They received a lamotrigine-valproate combination resulting in an excellent improvement; however, after 2-3 years of therapy, both patients were hospitalized because of continuous disabling myoclonic jerks. The dosage of lamotrigine was the same before and at the onset of myoclonus. When the severe myoclonus started, both patients had a higher serum lamotrigine level (16.5 and 17.7 mg/L, respectively) than in previous findings. Disabling myoclonus was also present during lamotrigine monotherapy with 15 mg/L serum level. Lamotrigine may severely worsen myoclonic phenomena in generalized epilepsies, in which adverse events may be dependent on drug serum level.


Asunto(s)
Anticonvulsivantes/efectos adversos , Epilepsias Mioclónicas/inducido químicamente , Triazinas/efectos adversos , Adolescente , Adulto , Anticonvulsivantes/sangre , Electroencefalografía , Electromiografía , Epilepsias Mioclónicas/fisiopatología , Epilepsia Generalizada/complicaciones , Epilepsia Generalizada/tratamiento farmacológico , Epilepsia Generalizada/fisiopatología , Humanos , Lamotrigina , Masculino , Triazinas/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA